It was identified less than one decade ago in patients with sepsis and appears to be superior to other biomarkers (IL-6 and PCT), as well as to infection site and blood culture, for the diagnosis of severe sepsis of bacterial origin [7,20]. This evidence concerns the gene IL6 and infection.